We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Moleculin Biotech Inc | TG:MOL | Tradegate | Ordinary Share |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.00 | - |
BUDAPEST--MOL Nyrt. (MOL.BU), a Hungary-based Central European oil and gas company has been offered four "highly prospective" licenses in the UK Continental Shelf after bidding in the UK's 28th Seaward Licensing Round, MOL announced in a stock exchange filing Thursday.
MAIN FACTS:
- If MOL accepts the licenses, it will become an operator in the North Sea
- All offered licenses have Drill or Drop well obligations and are located in the Central and Northern UK North Sea.
- MOL has focused on its strategic play knowledge and capabilities and will be seeking to further define and de-risk these latest license additions to its current UK portfolio of assets through quantified and technology driven exploration.
- MOL first acquired four offshore licenses in December 2013, followed by six further offshore license purchases in June this year.
- MOL opened up 0.3% in Thursday's trading at HUF11,920.
Write to Veronika Gulyas at veronika.gulyas@wsj.com; Twitter: @VeronikaGulyas1
1 Year Moleculin Biotech Chart |
1 Month Moleculin Biotech Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions